Amundi’s Silicon Laboratories SLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.9M Sell
8,705
-1,760
-17% -$381K ﹤0.01% 1205
2026
Q1
$2.18M Sell
10,465
-5,795
-36% -$1.06M ﹤0.01% 1089
2025
Q4
$2.13M Buy
16,260
+8,658
+114% +$1.14M ﹤0.01% 1153
2025
Q3
$1.03M Sell
7,602
-1,166
-13% -$159K ﹤0.01% 1150
2025
Q2
$1.34M Buy
8,768
+1,009
+13% +$119K ﹤0.01% 1150
2025
Q1
$769K Sell
7,759
-6
-0.1% -$811 ﹤0.01% 1395
2024
Q4
$994K Sell
7,765
-12,640
-62% -$1.45M ﹤0.01% 1404
2024
Q3
$2.31M Sell
20,405
-622
-3% -$69.4K ﹤0.01% 1122
2024
Q2
$2.34M Sell
21,027
-29,349
-58% -$3.62M ﹤0.01% 1079
2024
Q1
$5.92M Buy
50,376
+28,046
+126% +$3.72M ﹤0.01% 936
2023
Q4
$2.78M Sell
22,330
-6,863
-24% -$751K ﹤0.01% 1111
2023
Q3
$3.19M Buy
29,193
+7,628
+35% +$1.05M ﹤0.01% 1064
2023
Q2
$3.46M Sell
21,565
-11,982
-36% -$1.81M ﹤0.01% 1055
2023
Q1
$5.63M Buy
33,547
+22,784
+212% +$3.83M ﹤0.01% 973
2022
Q4
$1.62M Buy
10,763
+1,982
+23% +$261K ﹤0.01% 1231
2022
Q3
$1.17M Buy
+8,781
New +$1.17M ﹤0.01% 1218

Other funds holding SLAB

Amundi's SLAB Position: Q2 2026 in Review

Amundi reduced its Silicon Laboratories (SLAB) stake by 17% in Q2 2026, selling an estimated $381K and leaving 8,705 shares worth $1.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1205.

Amundi first reported a position in SLAB in Q3 2022 and has held it in 16 quarters since. The position peaked at $5.92M in Q1 2024. 352 funds tracked by Wall St. Rank hold SLAB as of Q2 2026.

  • Amundi held 8,705 shares of Silicon Laboratories worth $1.9M as of Q2 2026.
  • Amundi sold 1,760 Silicon Laboratories shares in Q2 2026, an estimated $381K.
  • Silicon Laboratories made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1205 holding.
  • Amundi first reported a position in Silicon Laboratories in Q3 2022 and has held it in 16 quarters since.
  • Amundi's Silicon Laboratories position peaked at $5.92M in Q1 2024.
  • 352 funds tracked by Wall St. Rank held Silicon Laboratories as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.